The Malaysian Journal of Medical Sciences has in its 25 years “Silver Jubilee” achieved another milestone of being visible to the biomedical community when it was accepted in PubMed. The journal aim to increase its readership so as to increase impact in the biomedical field amongst its Asian readers despite having a high rejection rate. This was done to maintain quality of the manuscripts published over the years. PubMed listing should enable more manuscripts to be cited as its the leading biomedical journal for the Asian community.

The most recent Malaysian Journal of Medical Sciences (MJMS)–MyCite report has shown that it has achieved a level becoming of a leading national medical science journal. This editorial reports on submission and acceptance rates of MJMS throughout the year 2013 and their geographical contributors. Our rejection rate of 29.76% with a 21.95% withdrawal rate because of poor quality of content and data as well as plagiarism indicates the seriousness of this journal to maintain the integrity and quality of it’s scientific data.

In 1986, the Malaysian Journal of Medical Sciences (MJMS) began as the small and newly established journal Diagnosa, established by the Universiti Sains Malaysia School of Medicine. After 28 years in the publishing industry, we have received the honor of a listing as a local journal in the Emerging Sources Citation Index (ESCI) created by Thomson Reuters (TR) to spotlight emerging high-quality scientific publications. The editorial team of MJMS looks forward to the next step in the march of progress toward the status of an international journal.